Opsonization of T1M1 group A Streptococcus: dynamics of antibody production and strain specificity.
暂无分享,去创建一个
[1] E. Kaplan,et al. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera. , 1999, The Journal of infectious diseases.
[2] J. Andersson,et al. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. , 1999, The Journal of infectious diseases.
[3] D. Stevens,et al. Type-specific opsonophagocytosis of group A Streptococcus by use of a rapid chemiluminescence assay. , 1999, The Journal of infectious diseases.
[4] J. Andersson,et al. Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] J. Musser,et al. Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] G. Lindahl,et al. Expression of two different antiphagocytic M proteins by Streptococcus pyogenes of the OF+ lineage. , 1998, Journal of immunology.
[7] J. Vuopio‐Varkila,et al. Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. , 1997, The Journal of infectious diseases.
[8] C. Jorup-Rönström,et al. Erysipelas: clinical and bacteriologic spectrum and serological aspects. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] E. Kaplan. Recent epidemiology of group A streptococcal infections in North America and abroad: an overview. , 1996, Pediatrics.
[10] M. Wessels,et al. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci , 1996, Infection and immunity.
[11] A. Podbielski,et al. M‐related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes , 1996, Molecular microbiology.
[12] A. Österlund. Epidemiological observations on Streptococcus pyogenes serotype T1 in Uppsala county, Sweden 1989–1995 , 1996 .
[13] D. Stevens. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. , 1995, Emerging infectious diseases.
[14] J. Zabriskie,et al. Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies. , 1995, The Journal of infectious diseases.
[15] U. Andersson,et al. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B , 1994, Infection and immunity.
[16] B. Schwartz,et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome , 1993, Infection and immunity.
[17] M. P. Harbaugh,et al. Nucleotide substitutions and small‐scale insertion produce size and antigenic variation in group A streptococcal M1 protein , 1993, Molecular microbiology.
[18] J. P. Davis,et al. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. , 1993, JAMA.
[19] S. Holm,et al. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. , 1992, The Journal of infectious diseases.
[20] L. Burman,et al. Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. , 1991, The Journal of infectious diseases.
[21] V. Fischetti,et al. Streptococcal M protein: molecular design and biological behavior , 1989, Clinical Microbiology Reviews.
[22] R. Zwaag,et al. Acquisition of Group A streptococcal M protein antibodies , 1985, Pediatric infectious disease.
[23] R. Facklam,et al. Type-specific immunity and pharyngeal acquisition of group A Streptococcus. , 1982, American journal of epidemiology.
[24] R. Lancefield. Current knowledge of type-specific M antigens of group A streptococci. , 1962, Journal of immunology.
[25] R. Lancefield. PERSISTENCE OF TYPE-SPECIFIC ANTIBODIES IN MAN FOLLOWING INFECTION WITH GROUP A STREPTOCOCCI , 1959, The Journal of experimental medicine.
[26] R. Lancefield. DIFFERENTIATION OF GROUP A STREPTOCOCCI WITH A COMMON R ANTIGEN INTO THREE SEROLOGICAL TYPES, WITH SPECIAL REFERENCE TO THE BACTERICIDAL TEST , 1957, The Journal of experimental medicine.
[27] F. W. Denny,et al. Type-specific streptococcal antibody. , 1957, The Journal of clinical investigation.
[28] J. Musser,et al. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. , 1997, JAMA.